Interrad Medical Inc. raised $10 million in a Series C round it plans to spend on the development and commercialization of its SecurAcath catheter stabilization device.
The private placement with high-net-worth angels backing the Minneapolis-based med-tech company was brokered by the RBC Wealth Management Group.
"Recently raising 10 million dollars, in a volatile economy, is clearly a testament to the promise of the SecurAcath technology," said Joe Goldberger, Interrad president & CEO, in prepared remarks.
Sign up to get our free newsletters delivered straight to your inbox
SecurAcath is currently the only catheter stabilization device not attached by adhesives or sutures.
Here’s a roundup of other dealflow and investment news:
Healthcare scheduling app ZocDoc raked in $25 million from Wall Street powerhouse Goldman Sachs, bringing the company’s total investment to $95 million.
Read More
Menlo Park, Calif.-based CardioKinetix, Inc. raised $44 million in Series E financing for its Parachute ventricular partitioning device.
Read More
Advanced imaging startup Diagnostic Photonics raised $1.3 million in investment equity.
Read More
Spine surgery device maker SpineGuard won $6.2 million from investors to further its PediGuard franchise.
Read More
CareCloud raised $20 million in Series A funding, led by Intel Capital and Norwest Venture Partners.
Read More
Surgical implant company Si-Bone landed $16 million in financing to further the growth of its iFuse joint implant system.
Read More
Atlanta Catheter Therapies raised a $2.98 million is Series A equity for its Occlusion Perfusion Catheter.
Read More
Boston, Mass.-based AcuityBio won a $1.4 million grant to continue the development of its drug-eluting ABC Mesh for use in patients with lung caner.
Read More
Neuroblocking device-maker EnteroMedics announced the closing of its previously announced public offering at $14.5 million.
Read More.